Ketamine (0.5 mg/kg)
Sponsors
Washington University School of Medicine, Children's Cancer Hospital Egypt 57357, Assiut University, Soterix Medical, Dr. Lutfi Kirdar Kartal Training and Research Hospital
Conditions
Anesthesia, GeneralBrain TumorCritical IllnessDeliriumDepression / Major Depressive DisorderDepressive SymptomsElectroconvulsive TherapyEpilepsy
Phase 1
Phase 2
Subanesthetic Ketamine Infusions for Depressive Symptoms in Intensive Care Unit Patients
RecruitingNCT07639359
Start: 2026-05-14End: 2028-06-01Target: 50Updated: 2026-09-02
Behavioural Activation Therapy and Ketamine for Treatment-Resistant Depression
Not yet recruitingNCT07801703
Start: 2026-09-01End: 2029-09-01Target: 60Updated: 2026-09-03
Phase 3
The Prevention of Delirium and Complications Associated With Surgical Treatments Multi Center Clinical Trial
CompletedNCT01690988
Start: 2014-02-01End: 2017-07-31Updated: 2018-06-06
Effect of Different Anesthetic Drugs on Electrocorticography (ECOG).
Active, not recruitingNCT07165262
Start: 2025-08-18End: 2027-03-31Updated: 2025-09-10
Phase 4
Unknown Phase
Induction Agents in ECT: Effects on Seizure Duration, Quality, and Recovery
CompletedNCT07596095
Start: 2024-07-17End: 2025-12-31Updated: 2026-05-19
Intramuscular Ketamine for Suicidal Patients in the Evanston Hospital Emergency Department for Suicidal Distress
Enrolling by invitationNCT07810023
Start: 2026-09-10End: 2027-05-01Target: 8Updated: 2026-09-09